Anti covid pill, Ema starts review on molnupiravir

The European Medicines Agency Ema has started the rolling review procedure for the anti Covid pill molnupiravir. This was announced by Merck (MSD outside the US) and Ridgeback Biotherapeutics, American companies partners in the development of the experimental oral antiviral drug for the treatment of Sars-CoV-2 infection in adults.